![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 10, 2012 6:09:06 PM
I disagree. I was one of those who voiced the opinion that they were probably implementing a delaying action until the unaffected ongoing trials developed their MOS data - which are still on course for generating very good news (I'm sure with your history you will be unable to agree with that assessment regarding the upcoming trial information).
They didn't have to stick their necks out like they did with their new statements regarding the status of the 2nd line NSCLC trial but they chose to and I appreciate the effort and understand the limitations on being able to provide more details. I'll admit they didn't stick their necks out far but IMO it was certainly more than they had to, especially considering that it is providing unnecessary ammo for those that may proceed with legal actions against PPHM regarding the trial data.
They have great revenues out of Avid, Cotara PIII trial design approval from the FDA (for an orphan drug that has legal non-compete protection if it pans out), operating capital for a year, with reduction in burn rates due to in-progress trial expenses winding down (for now) with relatively short term - within 3 months - expected trial news that based on dates is expected by many here to be very positive. The same type of date analysis that was done on this board for the 2nd line NSCLC trials that turned out to be fairly accurate and had you and AF actually starting to sweat until the coding discrepancies arose. Luckily those coding issues came along to give you and people like AF a lifeline to latch onto to save your reputations from those very embarrassing postings regarding the ineffectiveness of Bavi. We note the drug hasn't been stated to be a failure and we also note that you chose to use the coding errors as justification of your position that Bavi is a failure. Do you really expect that kind of logic to make sense to most people?
Most people here don't expect you to discuss this stock with what we believe is an unbiased view. We have your published history vs. the performance of the drugs to base our view on.
I have recently viewed a video of Cramer clearly spelling out his beliefs and ethics for the Street.com people on how to do business when a company's stock price is going against his investment position.
If you haven't seen the video here is the link. You may want to view it if you haven't already:
Most of us here on this board know AF is tied at the hip to the Street.com and we know that you and AF historically post negative pieces about PPHM in what appears to be a ridiculously coordinated fashion.
With all due respect and IMO you are not an accurate source of information regarding the ACTUAL performance of the PPHM drug platform and I also believe that people should ignore your advice.
Its unfathomable to me why you feel the need to constantly post on this board.
Do you see yourself as the savior for all the possible new investors being "hoodwinked" by Peregrine? Do you feel so insulted by the majority of posters here that constantly state your advice is blatant bashing that you feel the need for revenge to keep coming back to spread your negative opinions about this stock?
You obviously must not be invested in Peregrine (wouldn't it be a hoot if you actually are invested in this stock and that information was made public; boy I guess the laugh would be on us wouldn't it) and there are literally hundreds of Biotech stocks out there for you to provide advice on; its just a great curiosity to me why you are always hanging around this stock and posting on this board. Don't you know anything about those other Biotech stocks to provide valuable information to the investing public? Do you only have a small set of knowledge in the Biotech field?
Well, anyway, thanks again for trying to help us (for the umpteenth time) with your information Dew and have a good night.
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM